Microcap Speculators
Here at microcap speculators we are in search of the very best speculative stocks. The reason why we are so interested in locating the top small cap stocks is because cheap illiquid stocks on Monday could be highly valued liquid stocks the next. Remember to never invest more into a speculative stock than you can afford to lose, and this is the key because should you be willing to gamble with your principal, it could pay off in a big way for you.
SUBSCRIBE TO OUR MONTHLY NEWSLETTER
Boosts in R&D Spending Drive Biotech Innovation, BDO USA Analysis Finds - CPAPracticeAdvisor.com
July 24, 2017
Zacks.com |
Boosts in R&D Spending Drive Biotech Innovation, BDO USA Analysis Finds
CPAPracticeAdvisor.com Fueled by a desire for innovation and new medical breakthroughs, the biotech industry continues to enjoy substantial growth due to increased investment in research and development (R&D), according to the sixth annual study from BDO USA, LLP. The 2017 ... Biotech ETF Industry Outlook for Second Half 2017Zacks.com all 2 news articles » |
Davis biotech firm Marrone Bio makes first product shipments to Africa - Sacramento Bee
July 23, 2017
|
Davis biotech firm Marrone Bio makes first product shipments to Africa
Sacramento Bee Davis biotech firm Marrone Bio Innovations Inc. said Monday that it has shipped its first product to the African continent. MBI said it has shipped its biofungicide, Reysana, to Morocco for use by growers of tomatoes, grapes and cucurbits, a diverse ... and more » |
This Biotech Got A Price Hike, But Seesawed After A Three-Day Run ... - Investor's Business Daily
July 23, 2017
Investor's Business Daily |
This Biotech Got A Price Hike, But Seesawed After A Three-Day Run ...
Investor's Business Daily Sarepta stock toed the line Monday after a three-day run turned negative following its strong second-quarter report last week and a price-target hike. and more » |
Could This Small Biotech Break Out On A Tie-Up With Eli Lilly? - Investor's Business Daily
July 23, 2017
Investor's Business Daily |
Could This Small Biotech Break Out On A Tie-Up With Eli Lilly?
Investor's Business Daily Nektar Therapeutics (NKTR) stock neared a breakout Monday after announcing a deal with Eli Lilly (LLY) to develop an drug that could stoke the immune system to fight autoimmune and inflammatory conditions. XAutoplay: On | OffIn morning trading on the ... Biotech Movers: NeuroDerm Shares Soar on Sale to Japanese FirmTheStreet.com all 120 news articles » |
3 Large-Cap Biotech Stocks to Buy Now - Investorplace.com
July 23, 2017
Investorplace.com |
3 Large-Cap Biotech Stocks to Buy Now
Investorplace.com Last week was a swell one for the broader market, which saw multiple major indices hit all-time highs. The S&P 500 gained 0.52%, while the Nasdaq-100 tacked on 1.4% and hit uncharted territory. However, the party to watch is not the forest, but the ... |
3 Things In Biotech You Should Learn Today: July 24, 2017 - Seeking Alpha
July 23, 2017
Seeking Alpha |
3 Things In Biotech You Should Learn Today: July 24, 2017
Seeking Alpha Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research! |
San Diego cancer biotech raises $38.6 million - The San Diego ... - The San Diego Union-Tribune
July 23, 2017
The San Diego Union-Tribune |
San Diego cancer biotech raises $38.6 million - The San Diego ...
The San Diego Union-Tribune eFFECTOR Therapeutics seeks to control how proteins are made to treat cancers. and more » |
Risk-On Attitude Drive Stocks and Biotech Higher - Investopedia
July 23, 2017
|
Risk-On Attitude Drive Stocks and Biotech Higher
Investopedia If we use ETFs as a proxy for sectors, then it should come as no surprise that the SPDR S&P 500 Biotech ETF (XBI) is by far the best performer in 2017, up nearly 37 percent. That's followed, in a distant second place, by the Technology Select Sector ... |